1	Un	Un		C0205447_1	calificador_1	0-2	4_QUEST_clinical_caseMIR	SENT1	-	-
2	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	3-9	4_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	10-12	4_QUEST_clinical_caseMIR	SENT1	-	-
4	25	25		-	-	13-15	4_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	16-20	4_QUEST_clinical_caseMIR	SENT1	-	-
6	presenta	presentar	VMIP3S0	-	-	21-29	4_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	30-32	4_QUEST_clinical_caseMIR	SENT1	-	-
8	forma	forma	NCFS000	C0348078	atributo	33-38	4_QUEST_clinical_caseMIR	SENT1	-	-
9	brusca	brusco	AQ0FS0	C0443162	calificador	39-45	4_QUEST_clinical_caseMIR	SENT1	-	-
10	astenia	astenia	NCFS000	C0004093#C3714552	hallazgo	46-53	4_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
11	e	y	CC	C1706368	calificador	54-55	4_QUEST_clinical_caseMIR	SENT1	-	-
12	ictericia	ictericia	NCFS000	C0022346	hallazgo	56-65	4_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	detectando	detectar	VMG0000	-	-	66-76	4_QUEST_clinical_caseMIR	SENT1	-	-
14	se	se	PP3CN000	-	-	76-78	4_QUEST_clinical_caseMIR	SENT1	-	-
15	unas	uno	DI0FP0	C0205447	calificador	79-83	4_QUEST_clinical_caseMIR	SENT1	-	-
16	Transaminasas	transaminasa	NCFP000	C1152208#C0002594	función_biológica#sustancia	84-97	4_QUEST_clinical_caseMIR	SENT1	-	-
17	(	(	Fpa	-	-	98-99	4_QUEST_clinical_caseMIR	SENT1	-	-
18	ALT	alanina_aminotransferasa_(o_tgp)	NC00YL0	-	-	99-102	4_QUEST_clinical_caseMIR	SENT1	-	-
19	y	y	CC	C1706368	calificador	103-104	4_QUEST_clinical_caseMIR	SENT1	-	-
20	AST	aspartato_transaminasa	NC00YL0	-	-	105-108	4_QUEST_clinical_caseMIR	SENT1	-	-
21	)	)	Fpt	-	-	108-109	4_QUEST_clinical_caseMIR	SENT1	-	-
22	superiores	superior	AQ0CP0	C1282910	calificador	110-120	4_QUEST_clinical_caseMIR	SENT1	-	-
23	a	a	SPS00	-	-	121-122	4_QUEST_clinical_caseMIR	SENT1	-	-
24	2000	2000		-	-	123-127	4_QUEST_clinical_caseMIR	SENT1	-	-
25	UI	ui	NC00SC0	C0439453	calificador	128-130	4_QUEST_clinical_caseMIR	SENT1	-	-
26	/	/	Fh	-	-	130-131	4_QUEST_clinical_caseMIR	SENT1	-	-
27	L.	l.	NCFS000	-	-	131-133	4_QUEST_clinical_caseMIR	SENT1	-	-
28	Los	el	DA0MP0	-	-	134-137	4_QUEST_clinical_caseMIR	SENT1	-	-
29	marcadores	marcador	NCMP000	-	-	138-148	4_QUEST_clinical_caseMIR	SENT1	-	-
30	serológicos	serológico	AQ0MP0	C0205473	calificador	149-160	4_QUEST_clinical_caseMIR	SENT1	-	-
31	muestran	mostrar	VMIP3P0	-	-	161-169	4_QUEST_clinical_caseMIR	SENT1	-	-
32	el	el	DA0MS0	-	-	170-172	4_QUEST_clinical_caseMIR	SENT1	-	-
33	siguiente	siguiente	AQ0CS0	C0332282	atributo	173-182	4_QUEST_clinical_caseMIR	SENT1	-	-
34	patrón	patrón	NCMS000	C0449774	atributo	183-189	4_QUEST_clinical_caseMIR	SENT1	-	-
35	:	:	Fd	-	-	189-190	4_QUEST_clinical_caseMIR	SENT1	-	-
36	Anti-VHA	anti-vha	NCFS000	-	-	191-199	4_QUEST_clinical_caseMIR	SENT1	-	-
37	IgM	igm	NCMS000	-	-	200-203	4_QUEST_clinical_caseMIR	SENT1	-	-
38	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	204-212	4_QUEST_clinical_caseMIR	SENT1	-	-
39	,	,	Fc	-	-	212-213	4_QUEST_clinical_caseMIR	SENT1	-	-
40	HBsAg	hepatitis_b_surface_antigen_(antígeno_de_superficie_de_la_hepatitis_b_o_antígeno_australia)	NC00YL0	-	-	214-219	4_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	Negacion
41	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	220-228	4_QUEST_clinical_caseMIR	SENT1	-	-
42	,	,	Fc	-	-	228-229	4_QUEST_clinical_caseMIR	SENT1	-	-
43	anti-HBc	anti-hbc	RG	-	-	230-238	4_QUEST_clinical_caseMIR	SENT1	-	-
44	IgM	igm	NCMS000	-	-	239-242	4_QUEST_clinical_caseMIR	SENT1	-	-
45	positivo	positivo	AQ0MS0	C1446409	calificador	243-251	4_QUEST_clinical_caseMIR	SENT1	-	-
46	y	y	CC	C1706368	calificador	252-253	4_QUEST_clinical_caseMIR	SENT1	-	-
47	anti-VHC	anticuerpos_contra_el_virus_de_la_hepatitis_c	NC00YL0	-	-	254-262	4_QUEST_clinical_caseMIR	SENT1	-	-
48	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	263-271	4_QUEST_clinical_caseMIR	SENT1	-	-
49	.	.	Fp	-	-	271-272	4_QUEST_clinical_caseMIR	SENT1	-	-

1	¿	¿	Fia	-	-	273-274	4_QUEST_clinical_caseMIR	SENT2	-	-
2	Cuál	cuál	PT0CS000	-	-	274-278	4_QUEST_clinical_caseMIR	SENT2	-	-
3	es	ser	VSIP3S0	-	-	279-281	4_QUEST_clinical_caseMIR	SENT2	-	-
4	su	su	DP3CS0	-	-	282-284	4_QUEST_clinical_caseMIR	SENT2	-	-
5	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	285-296	4_QUEST_clinical_caseMIR	SENT2	-	-
6	?	?	Fit	-	-	296-297	4_QUEST_clinical_caseMIR	SENT2	-	-
7	:	:	Fd	-	-	297-298	4_QUEST_clinical_caseMIR	SENT2	-	-
8	.	.	Fp	-	-	298-299	4_QUEST_clinical_caseMIR	SENT2	-	-

